OI
MCID: ORT004
MIFTS: 64

Orthostatic Intolerance (OI) malady

Categories: Genetic diseases, Neuronal diseases, Rare diseases, Mental diseases, Cardiovascular diseases

Aliases & Classifications for Orthostatic Intolerance

About this section

Aliases & Descriptions for Orthostatic Intolerance:

Name: Orthostatic Intolerance 52 24 70 27 12
Mitral Valve Prolapse 11 27 50 38 39 13
Neurocirculatory Asthenia 11 24 39 13 68
Familial Orthostatic Tachycardia Due to Norepinephrine Transporter Deficiency 54
Cardiovascular Malfunction Arising from Mental Factors 11
Postural Tachycardia Syndrome Due to Net Deficiency 54
Orthostatic Intolerance Due to Net Deficiency 54
Mitral Valve Prolapse, Familial, X-Linked 68
Myxomatous Mitral Valve Prolapse 11
 
Systolic Click-Murmur Syndrome 11
Mitral Valve Prolapse Syndrome 68
Cardiovascular Neurosis 11
Mitral Leaflet Syndrome 11
Da Costa's Syndrome 11
Krishaber's Disease 11
Floppy Mitral Valve 11
Barlow's Syndrome 11
Oi 70

Characteristics:

Orphanet epidemiological data:

54

HPO:

64
orthostatic intolerance:
Inheritance: autosomal dominant inheritance

Classifications:



Summaries for Orthostatic Intolerance

About this section
MedlinePlus:38 Mitral valve prolapse (mvp) occurs when one of your heart's valves doesn't work properly. the flaps of the valve are "floppy" and don't close tightly. most people who have the condition are born with it. it also tends to run in families. most of the time, mvp doesn't cause any problems. rarely, blood can leak the wrong way through the floppy valve. this can cause palpitations (feelings that your heart is skipping a beat, fluttering, or beating too hard or too fast) shortness of breath cough fatigue, dizziness, or anxiety migraine headaches chest discomfort most people who have mitral valve prolapse (mvp) don't need treatment because they don't have symptoms and complications. if you need treatment for mvp, medicines can help relieve symptoms or prevent complications. very few people will need surgery to repair or replace the mitral valve. mvp puts you at risk for infective endocarditis, a kind of heart infection. to prevent it, doctors used to prescribe antibiotics before dental work or certain surgeries. now, only people at high risk of endocarditis need the antibiotics. nih: national heart, lung, and blood institute

MalaCards based summary: Orthostatic Intolerance, also known as mitral valve prolapse, is related to mitral valve prolapse, myxomatous 2 and mitral valve prolapse, myxomatous 3, and has symptoms including angina pectoris, angina pectoris and chest pain. An important gene associated with Orthostatic Intolerance is SLC6A2 (Solute Carrier Family 6 Member 2), and among its related pathways are Development_Leptin signaling via JAK/STAT and MAPK cascades and Doxorubicin Pathway (Cardiomyocyte Cell), Pharmacodynamics. Affiliated tissues include heart, lung and testes, and related mouse phenotypes are renal/urinary system and adipose tissue.

Disease Ontology:11 A mitral valve disease where one or both of the cusps of the mitral valve bulge or collapse backward in the left atrium during systole.

UniProtKB/Swiss-Prot:70 Orthostatic intolerance: Syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. It is associated with postural tachycardia. Plasma norepinephrine concentration is abnormally high.

Wikipedia:71 Orthostatic intolerance (OI) is the development of symptoms when standing upright which are relieved... more...

Description from OMIM:52 604715

Related Diseases for Orthostatic Intolerance

About this section

Diseases in the Orthostatic Intolerance family:

Chronic Orthostatic Intolerance

Diseases related to Orthostatic Intolerance via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 76)
idRelated DiseaseScoreTop Affiliating Genes
1mitral valve prolapse, myxomatous 212.6
2mitral valve prolapse, myxomatous 312.4
3familial mitral valve prolapse12.4
4chronic orthostatic intolerance12.3
5mitral valve prolapse 212.3
6mitral valve prolapse, familial, x-linked12.2
7hypogonadism mitral valve prolapse mental retardation12.1
8mitral valve prolapse, familial, autosomal dominant12.1
9hypogonadism-mitral valve prolapse-intellectual disability syndrome12.1
10osteogenesis imperfecta11.9
11osteogenesis imperfecta, type iv11.7
12osteogenesis imperfecta, type v11.7
13osteogenesis imperfecta, type viii11.6
14osteogenesis imperfecta, type iii11.6
15osteogenesis imperfecta, type xiii11.6
16osteogenesis imperfecta, type xiv11.6
17osteogenesis imperfecta, type xv11.6
18osteogenesis imperfecta, type i11.6
19osteogenesis imperfecta, type vii11.5
20osteogenesis imperfecta, type xi11.5
21osteogenesis imperfecta, type ii11.5
22postural orthostatic tachycardia syndrome11.5
23osteogenesis imperfecta, type x11.5
24osteogenesis imperfecta, type vi11.5
25osteogenesis imperfecta, type xii11.4
26perinatally lethal osteogenesis imperfecta11.3
27dentinogenesis imperfecta11.1
28microphthalmia, syndromic 211.1
29osteogenesis imperfecta, type ix10.9
30syncope10.4
31cerebritis10.3
32chronic fatigue syndrome10.2
33proliferating trichilemmal cyst10.2EDN1, NOS3
34traumatic glaucoma10.1EDN1, NOS3, POMC
35secernentea infections10.1FBN1, POMC
36epithelial malignant thymoma10.1ADRB1, ADRB2
37zellweger syndrome10.1EDN1, NOS2, NOS3
38pyelonephritis10.1EDN1, NOS2, NOS3
39autonomic dysfunction10.1
40viral hepatitis10.1EDN1, NOS2, NOS3
41hyperlipoproteinemia type iii10.1FBN1, POMC
42adenocarcinoma10.1ADRB2, EDN1
43indeterminate leprosy10.1EDN1, NOS3
44acute posterior multifocal placoid pigment epitheliopathy10.1ADRB2, EDN1, NOS3
45critical limb ischemia10.0ADRB1, ADRB2, EDN1
46skull base neoplasm10.0EDN1, FBN1, NOS3
47peritonitis10.0ECE1, EDN1
48schizophrenia10.0
49obesity10.0
50brucellosis10.0

Comorbidity relations with Orthostatic Intolerance via Phenotypic Disease Network (PDN):


Hypertension, EssentialChronic Myocardial Ischemia
Ischemic Heart DiseaseHeart Disease
EsophagitisDysthymic Disorder
Anxiety DisorderIntermediate Coronary Syndrome

Graphical network of the top 20 diseases related to Orthostatic Intolerance:



Diseases related to orthostatic intolerance

Symptoms & Phenotypes for Orthostatic Intolerance

About this section


Clinical features from OMIM:

604715

Human phenotypes related to Orthostatic Intolerance:

 64
id Description HPO Frequency HPO Source Accession
1 orthostatic tachycardia64 HP:0012173

UMLS symptoms related to Orthostatic Intolerance:


angina pectoris, chest pain, edema

MGI Mouse Phenotypes related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

41 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.8ADRA2B, EDN1, FBN1, NOS2, NOS3, POMC
2MP:00053758.7ACHE, ADRB1, ADRB2, FBN1, NOS2, NOS3
3MP:00053798.6ADRB1, ADRB2, ECE1, EDN1, FBN1, NOS2
4MP:00053808.5ADRA2A, ADRA2B, ADRA2C, ECE1, EDN1, FBN1
5MP:00053908.0ADRB1, ADRB2, ECE1, EDN1, FBN1, NOS2
6MP:00053977.7ACHE, ADRA2B, ADRB2, ECE1, FBN1, NOS2
7MP:00053697.4ACHE, ADRA2B, ADRB1, ADRB2, ECE1, EDN1
8MP:00053786.9ACHE, ADRA2B, ADRB1, ADRB2, ECE1, EDN1
9MP:00036316.8ACHE, ADRA2A, ADRA2C, ADRB2, ECE1, EDN1
10MP:00053866.8ACHE, ADRA2A, ADRA2B, ADRA2C, ADRB2, FBN1
11MP:00053856.5ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ECE1
12MP:00107686.2ACHE, ADRA2A, ADRA2B, ADRA2C, ADRB1, ECE1
13MP:00053765.8ACHE, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2

Drugs & Therapeutics for Orthostatic Intolerance

About this section

Drugs for Orthostatic Intolerance (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 276)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Metoprololapproved, investigationalPhase 4, Phase 221237350-58-6, 51384-51-14171
Synonyms:
(+/-)-Metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
BRD-A03623303-045-02-0
Beatrolol
Beloc
Beloc Duriles
Beloc-Duriles
BelocDuriles
Betaloc
Betaloc Astra
Betaloc-Astra
BetalocAstra
Betalok
C07202
CCRIS 4198
CGP 2175
CGP-2175
CGP2175
CHEBI:6904
CHEMBL13
CID4171
D008790
D02358
DB00264
DL-metoprolol
Dl-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
H 93-26
H 9326
 
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
LOPRESSIDONE
LS-122450
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
Lopressor
Lopressor HCT
Meijoprolol
Metohexal
Metoprolol
Metoprolol (USAN/INN)
Metoprolol Tartrate
Metoprolol [USAN:INN:BAN]
Metoprolol slow release
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Selo-Zok
Seloken
Seloken AstraZeneca Brand
Selopral
Seroken
Spesicor
Spesikor
TOPROL-XL
Tartrate, Metoprolol
Toprol
Toprol XL
Toprol-XL
UNII-GEB06NHM23
dl-Metoprolol
metoprolol
2
Droxidopaapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 13123651-95-8443940
Synonyms:
DOPS
Droxydopa
 
L-DOPS
L-Dihydroxyphenylserine
L-Threo-3,4-dihydroxyphenylserine
L-threo-dihydroxyphenylserine
3
MidodrineapprovedPhase 4, Phase 3, Phase 2, Phase 147133163-28-7, 42794-76-34195
Synonyms:
( -)-Midodrin hydrochloride
( -)-Midodrine hydrochloride
()-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride
(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-Midodrine hydrochloride
(+/-)-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride
3092-17-9
3092-17-9 (mono-hydrochloride)
42794-76-3
42794-76-3 (Parent)
43218-56-0
97476-58-9
A 4020 Linz
A-4020 Linz
AB00053715
AC1L1HMJ
AC1L2BU9
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride
Alphamine
Amatine
BPBio1_000157
BRD-A79981887-003-05-7
BSPBio_000141
BSPBio_003150
C07890
C12H18N2O4
C12H18N2O4.HCl
CHEBI:31847
CHEBI:6933
CHEMBL1200461
CID18340
CID4195
CPD000058833
D01307
D08220
DB00211
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DivK1c_000955
EINECS 255-945-3
EINECS 256-148-3
Gutron
HMS1568H03
HMS1922O03
Hipertan
I06-0865
IDI1_000955
KBio1_000955
KBio2_002121
KBio2_004689
KBio2_007257
 
KBio3_002650
KBioGR_000763
KBioSS_002121
LS-174957
LS-8042
LS-8052
M8277_FLUKA
M8277_SIGMA
MIDODRINE HYDROCHLORIDE
MLS001332567
MLS001332568
MLS002154233
Metligene
Midamine
Midodrin
Midodrina
Midodrina [INN-Spanish]
Midodrine (INN)
Midodrine HCL
Midodrine Monohydrochloride
Midodrine [BAN:INN]
Midodrine [INN:BAN]
Midodrine hydrochloride
Midodrine hydrochloride (JAN/USAN)
Midodrine hydrochloride [USAN:JAN]
Midodrine hydrochloride [USAN]
Midodrinum
Midodrinum [INN-Latin]
MolPort-003-666-473
MolPort-003-849-221
N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide
N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide
NCGC00095311-01
NCGC00178238-01
NCGC00178238-02
NINDS_000955
Prestwick0_000191
Prestwick1_000191
Prestwick2_000191
Prestwick3_000191
Prestwick_625
Pro-Amatine
Pro-Amatine (TN)
ProAmatine
SAM002564219
SBB066174
SMR000058833
SPBio_001390
SPBio_002062
SPECTRUM1503257
ST-1085
Spectrum2_001545
Spectrum3_001585
Spectrum4_000192
Spectrum5_000962
Spectrum_001641
St 1085
St. Peter 224
TL8002369
TS 701
UNII-59JV96YTXV
UNII-6YE7PBM15H
[+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol
midodrine
4
FludrocortisoneapprovedPhase 4, Phase 127127-31-131378
Synonyms:
(11beta)-9-Fluoro-11,17,21-trihydroxypregn-4-ene-3,20-dione
(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
127-31-1
4-08-00-03427 (Beilstein Handbook Reference)
9 .alpha. FF
9 Fluoro 17 Hydroxycortisone
9 Fluorocortisol
9 Fluorohydrocortisone
9 alpha FF
9 alpha Fludrohydrocortisone
9 alpha Fluoro 17 Hydroxycorticosterone
9 alpha Fluorohydrocortisone
9 alpha-Fludrocortisone
9 alpha-Fluoro-17-Hydroxycorticosterone
9 alpha-Fluorocortisol
9 alpha-Fluorohydrocortisone
9-AF
9-AFH
9-Fluoro-11-beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-17-Hydroxycortisone
9-Fluorocortisol
9-Fluorohydrocortisone
9-alpha-Fludrocortisone
9-alpha-Fluoro-17-hydroxycorticosterone
9-alpha-Fluorocortisol
9-alpha-Fluorohydrocortisone
9.alpha.-Fluoro-11.beta.,17.alpha.,21-trihydroxy-4-pregnene-3,20-dione
9.alpha.-Fluoro-17-hydroxycorticosterone
9.alpha.-Fluorocortisol
9.alpha.-Fluorohydrocortisone
9alpha-FLUOROCORTISOL
9alpha-Fludrocortisone
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-4-pregnene-3,20-dione
9alpha-Fluoro-17-hydroxycorticosterone
9alpha-Fluoro-hydrocortisone
9alpha-Fluorocortisol
AC1L1LI8
AC1Q5HJH
Alflorone
Astonin
Astonin H
Astonin Merck
Astonin-H
Astonin-H (TN)
BRN 3014278
 
C07004
C21H29FO5
CHEBI:50885
CHEMBL1201388
CID31378
D005438
D07967
DB00687
DB02478
EINECS 204-833-2
F-COL
F-Cortef
FCOL
Florinef
Fludrocortison
Fludrocortisona
Fludrocortisona [INN-Spanish]
Fludrocortisone
Fludrocortisone (INN)
Fludrocortisone [INN:BAN]
Fludrocortisonum
Fludrocortisonum [INN-Latin]
Fludrocortone
Fludrone
Fludronef
Fluodrocortisone
Fluohydrisone
Fluohydrocortisone
Fluorocortisol
Fluorocortisone
HSDB 3332
Hydrocortisone-9alpha-fluoro
LMST02030103
LS-118690
Merck Brand of Fludrocortisone
Merck, Astonin
MolPort-005-943-437
NCGC00181081-01
NSC 11318
NSC11318
Pregn-4-ene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy- (8CI)
Prestwick_648
StC 1400
U 5963
UNII-U0476M545B
WLN: L E5 B666 OV MUTJ A1 BF CQ E1 FV1Q FQ
ZINC04097304
ZK5
fludrocortisone
5
Propranololapproved, investigationalPhase 4, Phase 2, Phase 1, Early Phase 1228525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
6
BisoprololapprovedPhase 46366722-44-92405
Synonyms:
(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol
(+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol
(RS)-1-(4-(2-Isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol
1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[({2-[(1-methylethyl)oxy]ethyl}oxy)methyl]phenyl}oxy)propan-2-ol
1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)propan-2-ol
66722-44-9
AB00514681
AC-18540
AC1L1DLQ
AKOS005110983
ARONIS24082
BISOPROLOL
BPBio1_000373
BSPBio_000339
Bisocor
Bisoprolol
Bisoprolol (USAN/INN)
Bisoprolol Fumarate
Bisoprolol Hemifumarate
Bisoprolol [USAN:BAN:INN]
Bisoprolol fumerate
Bisoprolol hemifumarate
Bisoprololum
Bisoprololum [Latin]
C06852
C18H31NO4
CHEBI:3127
CHEMBL645
CID2405
 
CL-297939
Cardicor
Concor
Condyline
Condylox
D02342
DB00612
Detensiel
EMD-33-512
EMD-33512
Emconcor
Emcor
Euradal
I01-7040
Isoten
L000133
LS-122509
MolPort-005-937-320
Monocor
NCGC00024868-02
NCGC00024868-03
NCGC00024868-04
NCGC00024868-05
Prestwick0_000330
Prestwick1_000330
Prestwick2_000330
Prestwick3_000330
SBB065120
SPBio_002260
Soloc
Soprol
UNII-Y41JS2NL6U
Zebeta
7Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15352
8Cholinesterase InhibitorsPhase 4, Phase 2, Phase 1592
9Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 123689
10Vasoconstrictor AgentsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 12122
11Cholinergic AgentsPhase 4, Phase 2, Phase 13992
12SympatholyticsPhase 4, Phase 3, Phase 2, Phase 1580
13Pyridostigmine BromidePhase 4, Phase 2, Phase 127101-26-8
14Adrenergic beta-1 Receptor AntagonistsPhase 4, Phase 2, Phase 1364
15Anti-Arrhythmia AgentsPhase 4, Phase 2, Phase 1, Early Phase 13093
16Adrenergic beta-AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11193
17Adrenergic AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11573
18BromidesPhase 4, Phase 2, Phase 1642
19Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 118340
20Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 14207
21Autonomic AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 110150
22AnticonvulsantsPhase 4, Phase 2, Phase 12695
23Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 3, Phase 110729
24Antiparkinson AgentsPhase 4, Phase 3, Phase 2, Phase 11574
25Vasodilator AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13543
26Adrenergic alpha-AgonistsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 11734
27Adrenergic AgonistsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 13027
28
CarbidopaapprovedPhase 2, Phase 3, Phase 118428860-95-934359, 38101
Synonyms:
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid--water (1/1)
(S)-(-)-carbidopa
(S)-(-)-carbidopa hydrate
(S)-(−)-carbidopa
(S)-alpha--Hydrazino-3,4-dihydroxy-alpha--methyl-benzenepropanoic acid monohydrate
(S)-carbidopa
(S)-carbidopa hydrate
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate
(αS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
27925-91-3
28860-95-9
31823-41-3
38821-49-7
AC-1676
AC1L1RFR
AC1L1Z32
AC1Q5QGW
Atamet
BB_SC-5095
Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)
C-126
C-DOPA
C126_SIGMA
C1335_SIGMA
CCRIS 5093
CHEBI:3395
CHEBI:39585
CHEMBL1200748
CHEMBL1201236
CID34359
CID38101
CPD-11550
Carbidopa (anhydrous)
Carbidopa Anhydrous
Carbidopa Monohydrate
Carbidopa [USAN:INN:BAN]
Carbidopa anhydrous
Carbidopa hydrate
Carbidopa, (S)-Isomer
Carbidopa, Entacapone, & Levodopa
Carbidopa-1-wasser
 
Carbidopum
Carbidopum [INN-Latin]
DB00190
EINECS 249-271-9
EU-0100382
HMS2089B12
Hadrazino-alpha-methyldopa
Hydrocinnamic acid, (-)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate
KINSON, 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-alpha-(3,4-dihydroxybenzyl)-alpha-hydrazinopropionic acid monohydrate
L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid
L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid
L-alpha-Methyldopahydrazine
L-α-methyldopahydrazine
LS-77199
Lodosin
Lodosyn
Lodosyn, Carbidopa
Lopac0_000382
MK 486
MK-485
MK-486
MLS000069628
MLS002207014
Methyldopahydrazine
MolPort-003-940-629
MolPort-005-934-181
N-Aminomethyldopa
NCGC00024596-01
NCGC00024596-03
NCGC00024596-05
NCGC00024596-06
S(-)-CARBIDOPA
S(-)-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate
S-(-)-Carbidopa
S-(-)-alpha-Hydrazino-3,4-dihydroxy-2-methylbenzenepropanoic acid
S1891_Selleck
SMP1_000057
SMR000058235
ST055523
Stalevo
Tocris-0455
UNII-KR87B45RGH
UNII-MNX7R8C5VO
alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid
alpha-Methyldopahydrazine
carbidopa
carbidopum monohydricum
29
MethyldopaapprovedPhase 3, Phase 114555-30-638853
Synonyms:
(-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate
(-)-a-methyldopa
(-)-alpha-methyldopa
(-)-methyldopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid
(S)-(-)-a-methyldopa
(S)-(-)-alpha-Methyldopa
(S)-(-)-alpha-methyldopa
133161-54-3
1339-75-9
2-Methyl-3-(3,4-dihydroxyphenyl)alanine
3,4-Dihydroxy-2-methylphenylalanine (ACD/Name 4.0)
3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE
3-Hydroxy-.alpha.-methyl-L-tyrosine
3-Hydroxy-alpha-methyl-L-tyrosine
4290-08-8
555-30-6
779-08-8
AC-11671
AC1L20K1
AC1Q29EL
AC1Q29EM
AMD
Aldoclor-150
Aldoclor-250
Aldomet
Aldomet (TN)
Aldometil
Aldomin
Aldoril 15
Aldoril 25
Aldoril D30
Aldoril D50
Aldoril, Dopamet, Dopegyt, Methyldopa
Alpha medopa
Alphamethyldopa
Anhydrous methyldopa
Apo Methyldopa Tab 125mg
Apo Methyldopa Tab 250mg
Apo Methyldopa Tab 500mg
Apo-Methyldopa
Apo-methyldopa
BIDD:GT0620
BPBio1_000365
BSPBio_000331
BSPBio_002021
Bayer 1440 L
Baypresol
Becanta
C07194
CCRIS 4671
CHEBI:61058
CHEMBL459
CID38853
D08205
DB00968
DivK1c_000142
Dopamet
Dopamethyperpax
Dopatec
Dopegit
Dopegyt
Dopergit
EINECS 209-089-2
EU-0100853
Grospisk
HMS1569A13
HMS1920N09
HMS2090B11
HMS2091F04
HMS500H04
HSDB 218
Hyperpax
Hypolag
IDI1_000142
KBio1_000142
KBio2_001417
KBio2_003985
KBio2_006553
KBio3_001521
KBioGR_000547
KBioSS_001417
L(-)-a-Methylalanine
L(-)-alpha-Methylalanine
L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methyl-Alanine
L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine
L-(-)-a-Methyl-a-methyl-Aldomin
L-(-)-alpha-Methyl-alpha-methyl-Aldomin
L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine
L-(a-MD)
L-(alpha-Md)
L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid
L-Methyl Dopa
L-Methyl dopa
 
L-Methyldopa
L-a-Methyl-(3, 4-dihydroxyphenyl)alanine
L-a-Methyldopa
L-alpha-Methyl DOPA
L-alpha-Methyl-(3, 4-dihydroxyphenyl)alanine
L-alpha-Methyl-3,4-dihydroxyphenylalanine
L-alpha-Methyldopa
LS-216
LT00847269
Lopac0_000853
METHYL DOPA (SEE ALSO METHYL DOPA SESQUIHYDRATE)
MK 351
MK-351
MLS000028644
Medomet
Medopa
Medopal
Medopren
Methoplain
Methyl dopa
Methyl-L-dopa
Methyldopa
Methyldopa (INN)
Methyldopa (L,-)
Methyldopa (anhydrous)
Methyldopa 125 Tab 125mg
Methyldopa 250 Tab
Methyldopa 500 Tab 500mg
Methyldopa anhydrous
Methyldopate
Methyldopate HCL
Methyldopum
Methyldopum [INN-Latin]
Metildopa
Metildopa [INN-Spanish]
Mk. b51
MolPort-001-792-485
NCGC00024667-01
NCGC00024667-02
NCGC00024667-03
NCGC00024667-05
NCGC00024667-06
NCGC00024667-08
NCI-C55721
NINDS_000142
NSC 169916
NSC169916
Novo-Medopa Tab 125mg
Novo-Medopa Tab 250mg
Novo-Medopa Tab 500mg
Novomedopa
Nr.C 2294
Nu-Medopa
Nu-Medopa Tab 125mg
Nu-Medopa Tab 250mg
Nu-Medopa Tab 500mg
Nu-medopa
Presinol
Presolisin
Prestwick0_000326
Prestwick1_000326
Prestwick2_000326
Prestwick3_000326
Prestwick_732
S1642_Selleck
SMR000059170
SPBio_001056
SPBio_002252
SPECTRUM1500403
Sedometil
Sembrina
Spectrum2_001068
Spectrum3_000501
Spectrum4_000054
Spectrum5_001295
Spectrum_000937
Tocris-0584
UNII-56LH93261Y
a-Methyl dopa
a-Methyl-L-3,4-dihydroxyphenylalanine
a-Methyl-L-dopa
a-Methyldopa (van)
alpha Medopa
alpha-Methyl dopa
alpha-Methyl-L-3,4-dihydroxyphenylalanine
alpha-Methyl-L-dopa
alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine
alpha-Methyldihydroxyphenylalanine
alpha-Methyldopa
alpha-Methyldopa (VAN)
alpha-Methyldopa (van)
alpha-methyl-L-dopa
l-3-(3,4-Dihydroxyphenyl)-2-methylalanine
l-alpha-Methyldopa
levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine
α-Methyl dopa
α-methyl-L-dopa
30
Methylprednisoloneapproved, vet_approvedPhase 2, Phase 3119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
31
DopamineapprovedPhase 3, Phase 2, Phase 1383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
32
LosartanapprovedPhase 3, Early Phase 1286114798-26-43961
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DUP 89
DuP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
 
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
LOSARTAN POTASSIUM
LS-78746
Lacidipine
Lortaan
Losartan
Losartan (INN)
Losartan Potassium
Losartan [INN:BAN]
Losartan monopotassium salt
Losartic
Losartic (TN)
MK-954
MK954
MolPort-003-666-553
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
SPBio_001893
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
Spectrum_001713
UNII-JMS50MPO89
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
losartan
losartan potassium
33
LevodopaapprovedPhase 3, Phase 1, Early Phase 140259-92-76047
Synonyms:
(-)-(3,4-Dihydroxyphenyl)alanine
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(-)-3-(3,4-dihydroxyphenyl)-L-alanine
(-)-Dopa
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(−)-3-(3,4-dihydroxyphenyl)-L-alanine
(−)-dopa
.Beta.-(3, 4-Dihydroxyphenyl)alanine
.Beta.-(3,4-Dihydroxyphenyl)-L-alanine
1E83F927-C221-46AA-B90A-81B33C5F3868
2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
23734-74-9
25525-15-9
3, 4-Dihydroxy-L-phenylalanine
3, 4-Dihydroxyphenylalanine
3,4-DIHYDROXYPHENYLALANINE
3,4-Dihydroxy-L-phenylalanine
3,4-Dihydroxyphenyl-L-alanine
3,4-Dihydroxyphenylalanine
3,4-Dihydroxyphenylalanine (VAN)
3,4-dihydroxy-L-phenylalanine
3,4-dihydroxyphenylalanine
3-(3,4-Dihydroxypheny
3-(3,4-Dihydroxyphenyl)-L-alanine
3-Hydroxy-L-tyrosine
34241-25-3
37830_FLUKA
587-45-1
59-92-7
72572-99-7
72573-00-3
88250-23-1
90638-38-3
AC-11686
AC1L1LOR
AC1Q4U7F
BIDD:GT0158
BPBio1_000059
BSPBio_000053
BSPBio_002354
Bendopa
Bio-0575
Biodopa
Brocadopa
C00355
C9H11NO4
CAS-59-92-7
CCRIS 3766
CHEBI:15765
CHEMBL1009
CID6047
Cerepap
Cidandopa
D 9628
D00059
D0600
D9628
D9628_SIGMA
DAH
DB01235
DOPA
Deadopa
Dihydroxy-L-phenylalanine
Dihydroxyphenylalanine
DivK1c_000452
Dopa
Dopaflex
Dopaidan
Dopal
Dopal-Fher
Dopal-fher
Dopalina
Dopar
Dopar (TN)
Doparkine
Doparl
Dopasol
Dopaston
Dopaston SE
Dopastone
Dopastral
Dopicar
Doprin
EINECS 200-445-2
EU-0100454
Eldopal
Eldopar
Eldopatec
Eurodopa
HMS1568C15
HMS1922J14
HMS2090O08
HMS2093N04
HMS501G14
HSDB 3348
Helfo DOPA
 
Helfo-Dopa
Helfo-dopa
IDI1_000452
IV Levodopa
InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14
Insulamina
KBio1_000452
KBio2_000934
KBio2_003502
KBio2_006070
KBioGR_001177
KBioSS_000934
L Dopa
L(-)-Dopa
L-(-)-Dopa
L-(3, 4-Dihydroxyphenyl)-.alpha.-alani
L-(3, 4-Dihydroxyphenyl)alanine
L-(o-Dihydroxyphenyl)alanine
L-.Beta.-(3,4-Dihydroxyphenyl)alanine
L-3,4-Dihydroxyphenylalanine
L-3,4-dihydroxyphenylalanine
L-3-(3,4-Dihydroxyphenyl)-Alanine
L-3-(3,4-Dihydroxyphenyl)alanine
L-3-Hydroxytyrosine
L-4-5-Dihydroxyphenylalanine
L-DOPA
L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa
L-Dihydroxyphenylalanine
L-Dopa
L-O-Dihydroxyphenylalanine
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-o-Hydroxytyrosine
LS-255
Laradopa
Larodopa
Ledopa
Levedopa
Levodopa
Levodopa (JP15/USP)
Levodopa (JP15/USP/INN)
Levodopa [USAN:INN:BAN:JAN]
Levodopum
Levodopum [INN-Latin]
Levopa
Lopac-D-9628
Lopac0_000454
MLS000028514
Maipedopa
MolPort-000-856-937
NCGC00015384-01
NCGC00016270-01
NCGC00016270-06
NCGC00093869-04
NINDS_000452
NSC 118381
NSC118381
PDSP1_001541
PDSP2_001525
Parda
Pardopa
Prestwick0_000017
Prestwick1_000017
Prestwick2_000017
Prestwick3_000017
Prestwick_185
Prodopa
Ro 4-6316
S1726_Selleck
SDCCGMLS-0066924.P001
SMR000058312
SPBio_000391
SPBio_001974
SPECTRUM2300205
Sobiodopa
Spectrum2_000496
Spectrum4_000539
Spectrum5_001899
Spectrum_000454
Syndopa
UNII-46627O600J
Veldopa
Weldopa
b-(3,4-Dihydroxyphenyl)-L-alanine
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)alanine
bmse000322
component of Sinemet
l)-L-alanine
nchembio.2007.55-comp26
nchembio.89-comp9
ne
β-(3,4-dihydroxyphenyl)alanine
34
Prednisoloneapproved, vet_approvedPhase 2, Phase 3119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
35
Mannitolapproved, investigationalPhase 328069-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
36
Metoclopramideapproved, investigationalPhase 3, Phase 1120364-62-54168
Synonyms:
(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
(metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-methoxy-5-chloroprocainamide
2576-84-3 (di-hydrochloride)
364-62-5
4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide)
4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
5-Chloro-2-methoxyprocainamide
54143-57-6 (mono-hydrochloride, mono-hydrate)
7232-21-5 (mono-hydrochloride)
AB00053498
AC1L1HKD
AKOS000280832
ARONIS24307
Apo-Metoclop
BPBio1_000217
BPBio1_001100
BRD-K75641298-001-01-5
BRD-K75641298-003-05-2
BRN 1884366
BSPBio_000197
BSPBio_002027
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
Biomol-NT_000082
C07868
C14H22ClN3O2
CAS-7232-21-5
CHEBI:107736
CHEMBL86
CID4168
CLOPRA-"YELLOW"
Cerucal
Clopra
Clopra-Yellow
Clopromate
D00726
DB01233
DEL
DEL 1267
DivK1c_000069
Duraclamid
EINECS 206-662-9
Elieten
Elieten (TN)
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastro-Timelets
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
HMS2089G16
IDI1_000069
Imperan
KBio1_000069
KBio2_002118
 
KBio2_004686
KBio2_007254
KBio3_001527
KBioGR_001307
KBioSS_002118
L001078
LS-20038
Lopac-M-0763
Lopac0_000762
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
Metoclopramide (JP15/INN)
Metoclopramide Hcl
Metoclopramide Hydrochloride
Metoclopramide Intensol
Metoclopramide Monohydrochloride, Monohydrate
Metoclopramide Omega
Metoclopramide [INN:BAN:JAN]
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metramid
MolPort-000-883-854
Moriperan
Mygdalon
N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
NCGC00015643-01
NCGC00015643-02
NCGC00015643-03
NCGC00015643-08
NCGC00024440-03
NCGC00024440-04
NCI60_003185
NINDS_000069
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Plasil (pharmaceutical)
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Prestwick0_000209
Prestwick1_000209
Prestwick2_000209
Prestwick3_000209
Primperan
Reclomide
Reglan
Reliveran
SPBio_001740
SPBio_002118
ST024773
Spectrum2_001720
Spectrum3_000504
Spectrum4_000964
Spectrum5_001449
Spectrum_001638
Terperan
Terperan (TN)
UNII-L4YEB44I46
bmse000779
metoclopramide
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)- (8CI)
37
NifedipineapprovedPhase 311821829-25-44485
Synonyms:
101539-70-2
101554-38-5
21829-25-4
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester
5-22-04-00268 (Beilstein Handbook Reference)
60299-11-8 (mono-hydrochloride)
AC-11618
AC1L1I9V
AC1Q4254
AKOS002942507
ARONIS24171
AWD Pharma Brand of Nifedipine
Adalat
Adalat (TN)
Adalat 10
Adalat 20
Adalat 5
Adalat CC
Adalat CR
Adalat Crono
Adalat FT
Adalat Ft
Adalat GITS
Adalat GITS 30
Adalat Gits
Adalat Gits 30
Adalat LA
Adalat LP
Adalat Oros
Adalat PA
Adalat Retard
Adalat XL
Adalate
Adalate LP
Adapine
Adapress
Adcock Ingram Brand of Nifedipine
Adipine XL
Afeditab
Afeditab CR
Afeditab CR (TN)
Alat
Aldipin
Alfadal
Alonix
Alonix S
Alpha-Nifedipine Retard
Angipec
Anifed
Anpine
Apo-Nifed
Aprical
Aprical long
BAY 1040
BAY A 1040
BAY-a 1040
BAYa1040
BCBcMAP01_000046
BIDD:GT0442
BIDD:PXR0034
BIM-0050796.0001
BPBio1_000271
BRN 0497773
BSPBio_000245
BSPBio_001391
BSPBio_002071
Bay-1040
Bay-a-1040
Bay1040
Bayer Brand of Nifedipine
Bio-0733
Bio1_000112
Bio1_000601
Bio1_001090
Bio2_000111
Bio2_000591
Bonacid
C07266
C17H18N2O6
CAS-21829-25-4
CBiol_001826
CCRIS 6074
CHEBI:7565
CHEMBL193
CID4485
CPD000058291
Calcibloc
Calcigard
Calcilat
Camont
Cardifen
Cardilat
Cardionorm
Chronadalate
Chronadalate LP
Chronadalate Lp
Citilat
Coracten
Coracten XL
Coral
Cordafen
Cordaflex
Cordalat
Cordicant
Cordilan
Cordipin
Cordipine
Corinfar
Corotrend
Corynphar
D00437
D009543
DB01115
Depin
Dignokonstant
Dilafed
Dilcor
Dipinkor
DivK1c_000313
Duranifin
EINECS 244-598-3
EU-0100819
Ecodipi
Ecodipin
Ecodipin E
Emaberin
Fedcor
Fedcor Retard
Fenamon
Fenamon SR
Fenamon Sr
Fenigidin
Fenihidin
Fenihidine
Fortipine LA
Glopir
HMS1361F13
HMS1568M07
HMS1791F13
HMS1920P19
HMS1989F13
HMS2051O03
HMS2089H11
HMS2091H20
 
HMS500P15
Hadipin
Hexadilat
I06-0051
I06-1286
IDI1_000313
IDI1_033861
Infedipin
Introcar
KB-1712P
KBio1_000313
KBio2_000111
KBio2_001459
KBio2_002400
KBio2_002679
KBio2_004027
KBio2_004968
KBio2_005247
KBio2_006595
KBio2_007536
KBio3_000221
KBio3_000222
KBio3_001571
KBio3_002879
KBioGR_000111
KBioGR_000627
KBioGR_002400
KBioSS_000111
KBioSS_001459
KBioSS_002405
KRKA Brand of Nifedipine
Kordafen
Korinfar
L001054
LS-1012
Lopac-N-7634
Lopac0_000819
MLS000028521
MLS000758222
MLS001148146
MLS001401371
Macorel
Megalat
MolPort-000-787-707
MolPort-006-822-492
Monohydrochloride, Nifedipine
Myogard
N 7634
N0528
N1fedilat
N7634_SIGMA
NCGC00015748-01
NCGC00015748-02
NCGC00015748-03
NCGC00015748-06
NCGC00015748-13
NCGC00024983-01
NCGC00024983-02
NCGC00024983-03
NCGC00024983-04
NCGC00024983-05
NCGC00024983-06
NCGC00024983-07
NCGC00024983-08
NCGC00091707-01
NINDS_000313
Nedipin
Nicardia
Nifangin
Nifar
Nifdemin
Nifebene
Nifecard
Nifecor
Nifedepat
Nifediac
Nifedical
Nifedical XL
Nifedicor
Nifedin
Nifedine
Nifedipine
Nifedipine (JP15/USP/INN)
Nifedipine Bayer Brand
Nifedipine GTIS
Nifedipine KRKA Brand
Nifedipine Monohydrochloride
Nifedipine Orion Brand
Nifedipine Pfizer Brand
Nifedipine Retard
Nifedipine [USAN:BAN:INN:JAN]
Nifedipine-GTIS
Nifedipino
Nifedipino [INN-Spanish]
Nifedipinum
Nifedipinum [INN-Latin]
Nifedipres
Nifedirex LP
Nifelan
Nifelat
Nifelat Q
Nifelate
Nifensar XL
Nificard
Nifidine
Nifipen
Niphedipine
Oprea1_788617
Orion Brand of Nifedipine
Orix
Oxcord
Pfizer Brand of Nifedipine
Pidilat
Prestwick0_000063
Prestwick1_000063
Prestwick2_000063
Prestwick3_000063
Prestwick_357
Procardia
Procardia (TN)
Procardia XL
S1808_Selleck
SAM001246963
SMR000058291
SPBio_001016
SPBio_002166
SPECTRUM1500431
STK735567
Sepamit
Slofedipine XL
Spectrum2_001058
Spectrum3_000516
Spectrum4_000074
Spectrum5_001278
Spectrum_000979
Tensipine MR
Tibricol
Tocris-1075
UNII-I9ZF7L6G2L
Vascard
ZINC19594578
Zenusin
cMAP_000042
nchembio.95-comp13
nifedipine
38
AtenololapprovedPhase 3, Phase 1, Phase 210429122-68-72249
Synonyms:
( inverted question mark)-Atenolol
(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
(+-)-Atenolol
(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
(?)-Atenolol
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid
2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide
2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide
2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide
29122-68-7
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide
4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide
60966-51-0
A 7655
A7655_SIGMA
AC-11142
AC1L1D99
AC1Q1QBX
AKOS005111050
ARONIS23884
Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)
Aircrit
Alinor
Altol
Anselol
Antipressan
Apo-Atenolol
Atcardil
Atecard
Atehexal
Atenblock
Atendol
Atenet
Ateni
Atenil
Atenol
Atenol 1A Pharma
Atenol 1A pharma
Atenol AL
Atenol Acis
Atenol Atid
Atenol CT
Atenol Cophar
Atenol Fecofar
Atenol GNR
Atenol Gador
Atenol Genericon
Atenol Heumann
Atenol MSD
Atenol NM Pharma
Atenol Nordic
Atenol PB
Atenol Quesada
Atenol Stada
Atenol Tika
Atenol Trom
Atenol Von CT
Atenol acis
Atenol ct
Atenol von ct
Atenol-Mepha
Atenol-Ratiopharm
Atenol-Wolff
Atenol-ratiopharm
Atenolin
Atenolol (JAN/USP)
Atenolol (JP15/USP/INN)
Atenolol [USAN:BAN:INN:JAN]
Atenolol [USAN:INN:BAN:JAN]
Atenololum
Atenololum [INN-Latin]
Atenomel
Atereal
Aterol
BB_SC-1519
BIM-0050109.0001
BRD-A20239487-001-02-5
BRN 2739235
BSPBio_002915
Betablok
Betacard
Betasyn
Betatop GE
Betatop Ge
Blocotenol
Blokium
CCRIS 4196
CHEBI:2904
CHEMBL24
CID2249
CPD000036768
Cardaxen
Cardiopress
Corotenol
Cuxanorm
D001262
D00235
DB00335
DivK1c_000057
Duraatenolol
Duratenol
 
EINECS 249-451-7
EINECS 262-544-7
EU-0100121
Evitocor
Farnormin
Felo-Bits
HMS1569L13
HMS1921H09
HMS2090I19
HMS2092D19
HMS500C19
HSDB 6526
Hipres
Hypoten
I01-3572
ICI 66,082
ICI 66082
ICI-66082
ICI66082
IDI1_000057
Ibinolo
InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
Internolol
Jenatenol
Juvental
KBio1_000057
KBio2_001844
KBio2_004412
KBio2_006980
KBio3_002415
KBioGR_000790
KBioSS_001844
L000116
LS-28557
LS-9707
Lo-Ten
Lo-ten
Lopac0_000121
Loten
Lotenal
MLS000069622
MLS001066372
MLS001074163
MLS001304038
MolPort-001-792-717
Myocord
NCGC00015007-07
NCGC00015007-13
NCGC00024566-03
NCGC00024566-04
NCGC00024566-05
NCGC00024566-06
NCGC00024566-07
NINDS_000057
Neatenol
Normalol
Normiten
Noten
Oprea1_448775
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
SAM002564193
SMR000036768
SPBio_001482
SPECTRUM1501127
STK528649
Scheinpharm Atenol
Seles Beta
Seles beta
Selobloc
Serten
Servitenol
Spectrum2_001411
Spectrum3_001448
Spectrum4_000435
Spectrum5_001509
Spectrum_001364
Stermin
Tenidon
Teno-Basan
Teno-basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
Tenormin (TN)
Tenormine
Tenormine [French]
Tensimin
Tensotin
Tredol
UNII-50VV3VW0TI
Unibloc
Uniloc
Vascoten
Vericordin
Wesipin
Xaten
atenolol
benzeneacetamide, 4-[2'-hydroxy-3
duratenol
39Natriuretic AgentsPhase 3, Phase 1, Phase 21697
40DihydroxyphenylalaninePhase 3, Early Phase 1143
41diureticsPhase 3, Phase 1, Phase 21418
42Neurotransmitter Uptake InhibitorsPhase 3, Phase 2, Phase 13521
43Psychotropic DrugsPhase 3, Phase 1, Phase 26430
44Atomoxetine HydrochloridePhase 3, Phase 2, Phase 1171
45Dopamine AntagonistsPhase 3, Phase 11093
46Aromatic Amino Acid Decarboxylase InhibitorsPhase 2, Phase 3, Phase 1153
47Tranquilizing AgentsPhase 3, Phase 14265
48Adrenergic alpha-2 Receptor AgonistsPhase 3, Phase 1, Phase 2980
49Neuroprotective AgentsPhase 2, Phase 3, Phase 11716
50HormonesPhase 2, Phase 314415

Interventional clinical trials:

(show top 50)    (show all 199)
idNameStatusNCT IDPhase
1Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)Unknown statusNCT01621464Phase 4
2Radical Prostatectomy and Perioperative Fluid TherapyCompletedNCT00771966Phase 4
3Propranolol to Treat Fainting Due to Sympathoadrenal ImbalanceCompletedNCT00060866Phase 4
4Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized StudyCompletedNCT02308124Phase 4
5Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01518946Phase 4
6A Study for Patients With Neurogenic Orthostatic HypotensionCompletedNCT00046475Phase 4
7Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic HypotensionCompletedNCT00555880Phase 4
8Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01515865Phase 4
9Clinical Trial for the Prevention of Vasovagal SyncopeCompletedNCT00118482Phase 4
10Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic HypotensionRecruitingNCT02586623Phase 4
11Dawn Simulation and Postural HypotensionRecruitingNCT02632318Phase 4
12Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IVRecruitingNCT01456481Phase 4
13Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging SubjectsRecruitingNCT02123056Phase 4
14Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)Active, not recruitingNCT02171988Phase 4
15A Phase IV Study in Subjects With Neurogenic Orthostatic HypotensionTerminatedNCT00046163Phase 4
16Post-Exercise Hypotension in Elderly Hypertensive MenUnknown statusNCT02415582Phase 3
17Effect of Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Hip-arthroplasty PatientsCompletedNCT02445898Phase 2, Phase 3
18Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip ArthroplastyCompletedNCT01707953Phase 3
19Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)CompletedNCT01132326Phase 3
20A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3
21Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3
22Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00738062Phase 3
23A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedNCT01176240Phase 3
24Stop Vasodepressor Drugs in Reflex SyncopeCompletedNCT02137278Phase 3
25Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSARecruitingNCT02071459Phase 2, Phase 3
26Peripheral Dopamine in Postural Tachycardia SyndromeActive, not recruitingNCT00685919Phase 2, Phase 3
27Treatment of Orthostatic HypotensionEnrolling by invitationNCT00581477Phase 3
28Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia SyndromeNot yet recruitingNCT03182725Phase 3
29Effectiveness of Surgical Mitral Valve Repair Versus Medical Treatment for People With Significant Mitral Regurgitation and Non-ischemic Congestive Heart FailureTerminatedNCT00608140Phase 3
30Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis PatientsTerminatedNCT01612078Phase 3
31A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3
32Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan SyndromeWithdrawnNCT01361087Phase 3
33Safety and Efficacy Study of a New Device for Making Neochordae in Mitral Valve RepairUnknown statusNCT01811537Phase 1, Phase 2
34Orthostatic Hypotension in Children With Acute Febrile IllnessUnknown statusNCT00452712Phase 2
35Acetylcholinesterase Inhibition and Orthostatic Hypotension in SC IUnknown statusNCT02307526Phase 2
36Cardiovascular Effects of Selective I(f)-Channel BlockadeUnknown statusNCT00865917Phase 2
37Fipamezole in Neurogenic Orthostatic HypotensionUnknown statusNCT00758849Phase 2
38The Effect of Ivabradine on Patients With Postural Tachycardia SyndromeUnknown statusNCT01761825Phase 2
39Feasibility Study of a Percutaneous Mitral Valve Repair System.CompletedNCT00209339Phase 1, Phase 2
40Sex Hormones and Orthostatic ToleranceCompletedNCT01153581Phase 2
41Non-Pharmacologic Therapy for Neurocardiogenic SyncopeCompletedNCT00096902Phase 2
42Propranolol to Treat Fainting in Children With Sympathoadrenal ImbalanceCompletedNCT00093860Phase 2
43Intravenous Norepinephrine for Orthostatic HypotensionCompletedNCT01285908Phase 1, Phase 2
44Phase II Study of Midodrine for Neurogenic Orthostatic HypotensionCompletedNCT00004268Phase 2
45Transcranial Electrical Stimulation for Management of Orthostatic Instability in Acute Cervical Spinal Cord InjuryCompletedNCT01874782Phase 2
46Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)CompletedNCT01971008Phase 2
47A Dose Response Trial Using 5 and 10 Mg of Midodrine HydrochlorideCompletedNCT00426842Phase 2
48Safety and Efficacy of L-NAME and Midodrine to Increase MAPCompletedNCT00835224Phase 2
49Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood DonationsCompletedNCT00302900Phase 2
50Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)RecruitingNCT02558972Phase 2

Search NIH Clinical Center for Orthostatic Intolerance


Cochrane evidence based reviews: mitral valve prolapse

Genetic Tests for Orthostatic Intolerance

About this section

Genetic tests related to Orthostatic Intolerance:

id Genetic test Affiliating Genes
1 Orthostatic Intolerance27 24 SLC6A2
2 Mitral Valve Prolapse27

Anatomical Context for Orthostatic Intolerance

About this section

MalaCards organs/tissues related to Orthostatic Intolerance:

36
Heart, Lung, Testes, Brain, Endothelial, Spinal cord, Tonsil

Publications for Orthostatic Intolerance

About this section

Articles related to Orthostatic Intolerance:

(show top 50)    (show all 274)
idTitleAuthorsYear
1
Orthostatic Intolerance and Postural Orthostatic Tachycardia Syndrome in Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome, Hypermobility Type: Neurovegetative Dysregulation or Autonomic Failure? (28286774)
2017
2
Dominant Transmission Observed in Adolescents and Families With Orthostatic Intolerance. (27773421)
2017
3
The effects of body weight status on orthostatic intolerance and predisposition to noncardiac syncope. (28112481)
2017
4
Orthostatic intolerance and autonomic dysfunction following bariatric surgery: A retrospective study and review of the literature. (27292926)
2016
5
Antroduodenal Manometry is Abnormal in Children Presenting with Orthostatic Intolerance and Gastrointestinal Symptoms. (26859090)
2016
6
Orthostatic intolerance and fatigue in the hypermobility type of Ehlers-Danlos Syndrome. (27094596)
2016
7
Dizziness and Orthostatic Intolerance In Pediatric Headache Patients. (27017026)
2016
8
Reduced Systolic Volume: Main Pathophysiological Mechanism in Patients with Orthostatic Intolerance? (27849259)
2016
9
Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome. (27729043)
2016
10
Adolescent Chronic Fatigue and Orthostatic Intolerance: Relationships Between Parental Attributes and Child Functioning. (27421749)
2016
11
Detailed Relationship Between the Pattern of Blood Pressure Change During the Valsalva Maneuver and the Degree of Orthostatic Hypotension During the Head-Up Tilt Test in Patients With Orthostatic Intolerance: A Retrospective Case-Control Study. (27175668)
2016
12
Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment options. (26608337)
2016
13
Orthostatic hypertension: An underestimated cause of orthostatic intolerance. (26806722)
2016
14
Mechanisms of orthostatic intolerance during heat stress. (26723547)
2016
15
Postoperative orthostatic intolerance: a common perioperative problem with few available solutions. (27638295)
2016
16
Cortical Morphology in Patients with Orthostatic Intolerance. (25895544)
2015
17
Reduced venous compliance - an important determinant for orthostatic intolerance in women with vasovagal syncope. (26561647)
2015
18
Orthostatic Intolerance Is Independent of the Degree of Autonomic Cardiovascular Adaptation after 60 Days of Head-Down Bed Rest. (26425559)
2015
19
Cerebral blood flow during HUTT in young patients with orthostatic intolerance. (26280217)
2015
20
Orthostatic Intolerance After ISS and Space Shuttle Missions. (26630196)
2015
21
Orthostatic Intolerance and Autonomic Dysfunction in Youth With Persistent Postconcussion Symptoms: A Head-Upright Tilt Table Study. (25706664)
2015
22
Autonomic activity and biomarker behavior in supine position and after passive postural stress in different orthostatic intolerance syndromes. (26320094)
2015
23
Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. (25882168)
2015
24
Cerebral hemodynamics in orthostatic intolerance with normal head-up tilt test. (26427910)
2015
25
Postexercise orthostatic intolerance: influence of exercise intensity. (26040636)
2015
26
Orthostatic intolerance in acute vestibular neuritis. (25659247)
2015
27
Orthostatic hypotension, orthostatic intolerance and frailty: The Irish Longitudinal Study on Aging-TILDA. (25687529)
2015
28
Variability of postural orthostatic tachycardia in patients with myalgic encephalomyelitis and orthostatic intolerance. (26374335)
2015
29
Slower lower limb blood pooling in young women with orthostatic intolerance. (25557726)
2015
30
Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance. (26198889)
2015
31
Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult. (26446285)
2015
32
Renin-aldosterone paradox in patients with myalgic encephalomyelitis and orthostatic intolerance. (24485613)
2014
33
Utility of corrected QT interval in orthostatic intolerance. (25180969)
2014
34
Prognostic analysis of orthostatic intolerance using survival model in children. (25382320)
2014
35
Orthostatic intolerance predicts mild cognitive impairment: incidence of mild cognitive impairment and dementia from the Swedish general population cohort Good Aging in SkAYne. (25429211)
2014
36
Neuropeptides and peptide hormones in syncope and orthostatic intolerance. (25299506)
2014
37
Orthostatic intolerance--an expression of autonomic disfunction in Parkinson's disease. (24741779)
2014
38
Managing the patient with episodic sinus tachycardia and orthostatic intolerance. (25524735)
2014
39
Effect of fludrocortisone acetate on chronic unexplained nausea and abdominal pain in children with orthostatic intolerance. (25222805)
2014
40
Slower lower limb blood pooling in young women with orthostatic intolerance. (25361596)
2014
41
Cardiac dysfunction and orthostatic intolerance in patients with myalgic encephalomyelitis and a small left ventricle. (24736946)
2014
42
Orthostatic intolerance is common in chronic disease--a clinical cohort study. (24809920)
2014
43
Orthostatic intolerance ambulation in patients using patient controlled analgesia. (23862002)
2013
44
Orthostatic intolerance and chronic fatigue syndrome--possible related conditions. (24340521)
2013
45
Postural tachycardia and orthostatic intolerance: chicken, egg or unrelated? (24190228)
2013
46
A clinical manifestation-based prediction of haemodynamic patterns of orthostatic intolerance in children: a multi-centre study. (23866994)
2013
47
Common syndromes of orthostatic intolerance. (23569093)
2013
48
Tilt angles and positive response of head-up tilt test in children with orthostatic intolerance. (24124665)
2013
49
Postoperative orthostatic intolerance and gender differences. (24156010)
2013
50
Clinical significance of orthostatic dizziness in the diagnosis of benign paroxysmal positional vertigo and orthostatic intolerance. (23790615)
2013

Variations for Orthostatic Intolerance

About this section

UniProtKB/Swiss-Prot genetic disease variations for Orthostatic Intolerance:

70
id Symbol AA change Variation ID SNP ID
1SLC6A2p.Ala457ProVAR_010022rs121918126

Clinvar genetic disease variations for Orthostatic Intolerance:

5
id Gene Variation Type Significance SNP ID Assembly Location
1SLC6A2NM_ 001172504.1(SLC6A2): c.1369G> C (p.Ala457Pro)SNVPathogenicrs121918126GRCh37Chr 16, 55731917: 55731917

Expression for genes affiliated with Orthostatic Intolerance

About this section
Search GEO for disease gene expression data for Orthostatic Intolerance.

Pathways for genes affiliated with Orthostatic Intolerance

About this section

Pathways related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

(show all 21)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.9EDN1, POMC
29.8NOS2, NOS3
39.8NOS2, NOS3
49.8NOS2, NOS3
5
Show member pathways
9.8NOS2, NOS3
69.8NOS2, NOS3
79.5EDN1, NOS2, NOS3
89.4ADRB1, ADRB2, POMC
99.4ECE1, NOS3, POMC
109.2ADRA2A, ADRB1, ADRB2
119.1ADRB1, ECE1, EDN1, NOS3
12
Show member pathways
9.0ADRB1, ADRB2, NOS2, NOS3
138.9ACHE, ADRB1, ECE1, EDN1
14
Show member pathways
8.6ADRA2A, ADRA2B, ADRA2C
15
Show member pathways
8.1ADRA2A, ADRA2B, ADRB1, ADRB2, EDN1
16
Show member pathways
7.9ADRA2A, ADRA2B, ADRA2C, NOS2, NOS3
17
Show member pathways
7.9ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2
18
Show member pathways
7.8ADRA2A, ADRA2B, ADRA2C, ADRB2, POMC
197.6ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, SLC6A2
20
Show member pathways
7.5ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, NOS3
21
Show member pathways
6.8ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ECE1

GO Terms for genes affiliated with Orthostatic Intolerance

About this section

Cellular components related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Weibel-Palade bodyGO:00330939.8ECE1, EDN1
2integral component of plasma membraneGO:00058877.7ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, SLC6A2

Biological processes related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

(show all 32)
idNameGO IDScoreTop Affiliating Genes
1arginine catabolic processGO:000652710.5NOS2, NOS3
2brown fat cell differentiationGO:005087310.5ADRB1, ADRB2
3diet induced thermogenesisGO:000202410.5ADRB1, ADRB2
4negative regulation of blood pressureGO:004577610.4NOS2, NOS3
5nitric oxide biosynthetic processGO:000680910.4NOS2, NOS3
6nitric oxide mediated signal transductionGO:000726310.4NOS2, NOS3
7regulation of blood vessel sizeGO:005088010.4EDN1, NOS3
8heat generationGO:003164910.4ADRB1, ADRB2
9negative regulation of multicellular organism growthGO:004001510.4ADRB1, ADRB2
10peptide hormone processingGO:001648610.4ECE1, POMC
11positive regulation of guanylate cyclase activityGO:003128410.4NOS2, NOS3
12positive regulation of vasodilationGO:004590910.4NOS2, NOS3
13negative regulation of cAMP biosynthetic processGO:003081810.3ADRA2A, EDN1
14negative regulation of calcium ion transportGO:005192610.3ADRA2A, NOS3
15regulation of sensory perception of painGO:005193010.1ADRA2C, EDN1
16regulation of blood pressureGO:000821710.1EDN1, NOS3, POMC
17regulation of sodium ion transportGO:000202810.1ADRB2, NOS3
18regulation of systemic arterial blood pressure by endothelinGO:00031009.8ECE1, EDN1, NOS3
19vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressureGO:00020259.7ADRB1, ADRB2
20regulation of insulin secretionGO:00507969.6ADRA2A, ADRA2C, NOS2
21adrenergic receptor signaling pathwayGO:00718759.4ADRA2B, ADRA2C, ADRB2
22activation of MAPK activity by adrenergic receptor signaling pathwayGO:00718839.4ADRA2A, ADRA2B, ADRA2C
23activation of protein kinase B activityGO:00321489.3ADRA2A, ADRA2B, ADRA2C
24epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathwayGO:00356259.3ADRA2A, ADRA2B, ADRA2C
25negative regulation of epinephrine secretionGO:00328119.3ADRA2A, ADRA2B, ADRA2C
26negative regulation of norepinephrine secretionGO:00107009.3ADRA2A, ADRA2B, ADRA2C
27platelet activationGO:00301689.2ADRA2A, ADRA2B, ADRA2C
28regulation of smooth muscle contractionGO:00069408.6ADRA2A, ADRA2B, ADRA2C, ADRB2
29adenylate cyclase-activating adrenergic receptor signaling pathwayGO:00718808.6ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2
30cell-cell signalingGO:00072678.5ADRA2B, ADRA2C, ADRB1, ADRB2, EDN1, POMC
31G-protein coupled receptor signaling pathwayGO:00071868.2ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, EDN1
32regulation of vasoconstrictionGO:00192297.9ADRA2A, ADRA2B, ADRA2C, ECE1, EDN1

Molecular functions related to Orthostatic Intolerance according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1arginine bindingGO:003461810.6NOS2, NOS3
2FMN bindingGO:001018110.6NOS2, NOS3
3NADPH-hemoprotein reductase activityGO:000395810.6NOS2, NOS3
4nitric-oxide synthase activityGO:000451710.6NOS2, NOS3
5alpha-2A adrenergic receptor bindingGO:003169410.5ADRA2C, ADRB1
6hormone activityGO:000517910.4EDN1, FBN1, POMC
7norepinephrine bindingGO:005138010.0ADRA2A, ADRB1, ADRB2
8tetrahydrobiopterin bindingGO:00346179.8NOS2, NOS3
9alpha2-adrenergic receptor activityGO:00049389.4ADRA2A, ADRA2B, ADRA2C
10adrenergic receptor activityGO:00049358.7ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2
11epinephrine bindingGO:00513798.7ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2
12G-protein coupled receptor activityGO:00049308.7ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2
13signal transducer activityGO:00048718.5ADRA2A, ADRA2B, ADRB1, ADRB2
14protein homodimerization activityGO:00428038.2ACHE, ADRA2A, ADRA2C, ADRB2, ECE1, NOS2
15protein bindingGO:00055156.0ACHE, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2

Sources for Orthostatic Intolerance

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet